REGN1193

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for REGN1193, covering 2015-03-13 to 2016-05-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of REGN1193 in Patients With Type 2 Diabetes Mellitus [Phase 1]